Sample size determination in superiority or non-inferiority clinical trials with time-to-event data under exponential, Weibull and Gompertz distributions

From MaRDI portal
Publication:6171850

DOI10.1080/03610918.2021.1879137arXiv1808.03831OpenAlexW3128742777WikidataQ115551216 ScholiaQ115551216MaRDI QIDQ6171850FDOQ6171850


Authors: Dong Han, Yawen Hou, Zheng Chen Edit this on Wikidata


Publication date: 18 July 2023

Published in: Communications in Statistics. Simulation and Computation (Search for Journal in Brave)

Abstract: To examine the effect of exponential, Weibull and Gompertz distributions on sample size determination for superiority trials (STs) or non-inferiority trials (NTs) with time-to-event data, we present two sample size formulas for STs or NTs based on Weibull and Gompertz distributions, respectively. The formulas are compared with the current exponential formula to examine their performance. The simulation results show that the sample size formula based on the Weibull distribution is the most robust among the three formulas in STs or NTs. We suggest that recognizing the appropriate distribution in advance is beneficial for proper project planning and that assuming a Weibull distributed survival time is most advantageous in STs or NTs.


Full work available at URL: https://arxiv.org/abs/1808.03831







Cites Work


Cited In (1)





This page was built for publication: Sample size determination in superiority or non-inferiority clinical trials with time-to-event data under exponential, Weibull and Gompertz distributions

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6171850)